Retatrutide 40 mg Multi-Dose Pen

Introducing the Retatrutide 40 mg multi-dose injection pen, designed for once-weekly administration. This innovative triple receptor agonist targets the GLP-1, GIP, and glucagon receptors.

Product Details:

• 40 mg total per pen
• 4 × 10 mg doses
• Once-weekly administration
• Includes:
• 1 multi-dose injection pen
• 12 disposable needles
• Instruction booklet

Features:

• Convenient prefilled pen design
• Easy weekly dosing
• Individually packaged for storage and transport

For research or use only as permitted under applicable laws and regulations. Always consult a qualified healthcare professional before using any medication.